Predicting Renal Outcome in IgA Nephropathy

Journal of the American Society of Nephrology

Volumn 8, Issue 2, 1997, Pages 199-207

  Radford, M Gene ^a   Donadio, James V ^a   Bergstralh, Erik J ^a   Grande, Joseph P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; KI 67 ANTIGEN;

ADULT; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; FEMALE; GLOMERULUS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; COHORT STUDIES; CREATININE; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KI-67 ANTIGEN; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031065782     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Berger J, Hinglais N: Les dépôts intracapillaires d'IgA-IgG. J Urol 74: 694-695, 1968
2. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. QJM 64: 709-727, 1987
3. Emancipator SN: IgA nephropathy: Morphologic expression and pathogenesis. Am J Kidney Dis 23: 451-462, 1994
4. Velo M, Lozano L, Egido J, Gutierrez-Millet V, Hernando L: Natural history of IgA nephropathy in patients followed up for more than ten years in Spain. Semin Nephrol 7: 346-350, 1987
5. Droz D: Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contrib Nephrol 2: 150-157, 1976
6. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984
7. Yokoyama H, Takaeda M, Wada T, Ogi M, Tomosugi N, Takabatake T, Abe T, Yoshimura M, Kida H, Kobayashi K: Intraglomerular expression of MHC class II and Ki-67 antigens and serum γ-interferon levels in IgA nephropathy. Nephron 62: 169-175, 1992
8. Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG: Proliferative activity of cyst epithelium in human renal cystic diseases. J Am Soc Nephrol 5: 1462-1468, 1995
9. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991
10. Nadasdy T, Laszik Z, Blick KE, Johnson LD, Silva FG: Proliferative activity of intrinsic cell populations in the normal human kidney. J Am Soc Nephrol 4: 2032-2039, 1994
11. Donadio JV, Bergstralh EJ, Offord KP, Holley KE, Spencer DC, for the Mayo Nephrology Collaborative Group: Clinical and histopathological associations with impaired renal function in IgA nephropathy. Clin Nephrol 41: 65-71, 1994
12. Nunnally JC: Psychometric Theory. New York, McGraw-Hill, 1978
13. Therneau TM, Sicks JD, Bergstralh EJ, Offord JR: Expected Survival Based on Hazard Rates. Section of Biostatistics, Mayo Clinic, Technical Report Series No. 52, March 1994.
14. Peto R, Peto J: Asymptotically efficient rank invariant procedures (with discussion). J R Stat Soc [A] 35: 185-207, 1972
15. Cox DR: Regression models and life-tables (with discussion). J R Stat Soc [B] 34: 187-220, 1972
16. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE, for the Mayo Nephrology Collaborative Group: A controlled trial of fish oil in IgA nephropathy. N Engl J Med 331: 1194-1199, 1994
17. Beukof JR, Kardaun O, Schaafsma W, Poortema K, Donker AJ, Hoedemaeker PJ, van der Hem GK: Toward individual prognosis of IgA nephropathy. Clin Invest 29: 549-556, 1986
18. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, Duca G: Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 59: 363-378, 1986
19. Rekola S, Bergstrand A, Bucht H: IgA nephropathy: A retrospective evaluation of prognostic indices in 176 patients. Scand J Urol Nephrol 23: 37-50, 1989
20. Bogenschutz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Gartner HV: IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 10: 137-147, 1990
21. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F: Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis 18: 12-19, 1991
22. Johnston PA, Brown JS, Braumholtz DA, Davison AM: Clinico-pathological correlations and long-term follow-up of 253 United Kingdom patients with IgA nephropathy: A report from the MRC glomerulonephritis registry. Q J Med 84: 619-627, 1992
23. Katafuchi R, Oh Y, Hori K, Komota T, Yanase T, Ikeda K, Omura T, Fujimi S: An important role of glomerular segmental lesions on progression of IgA nephropathy: A multivariate analysis. Clin Nephrol 41: 191-198, 1994
24. Ibels LS, Gyory AZ: IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 73: 79-102, 1994
25. Nicholls KM, Fairley KF, Dowling JP, Kincaid-Smith P: The clinical course of mesangial IgA associated nephropathy in adults. Q J Med 53: 227-250, 1984
26. Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH: IgA nephropathy: Presentation, clinical course, and prognosis in children and adults. Am J Kidney Dis 4: 192-200, 1984
27. Nath KA: Tuberulointerstitial changes as a major determinate in the progression of renal damage. Am J Kidney Dis 20: 1-17, 1992
28. Bennett WM, Walker RG, Kincaid-Smith P: Renal cortical interstitial volume in mesangial IgA nephropathy: Dissociation from creatinine clearance in serially biopsied patients. Lab Invest 47: 330-335, 1982
29. Hood SA, Velosa JA, Holley KE, Donadio JV Jr: IgA-IgG nephropathy: Predictive indices of progressive disease. Clin Nephrol 16: 55-62, 1981
30. Droz D, Kramar A, Nawar T, Noel LH: Primary IgA nephropathy prognostic factors. Contrib Nephrol 40: 202-207, 1984
31. Niemir ZI, Stein H, Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48: 1530-1541, 1995
32. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RS, Junor BJ, Briggs JD, Connell JM, Jardine AG: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542, 1995
33. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion polymorphism of the angiotensin converting enzyme in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162-2169, 1995
34. 2-microglobulin. Ann Intern Med 116: 905-909, 1992
35. 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol 6: 1666-1669, 1995